GeneDx Holdings Corp. Warrant

A securities class action lawsuit has been filed against GeneDx Holdings Corp. for alleged misrepresentations regarding the Fabric acquisition's impact on the company's business. Investors who purchased GeneDx common stock between April 16, 2025 and May 4, 2026 may be entitled to compensation. The lead plaintiff deadline is August 3, 2026.

A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) for allegedly making material misstatements about the viability of its $51 million acquisition of Fabric Genomics. The lawsuit covers investors who purchased WGS stock between April 16, 2025, and May 4, 2026. GeneDx's stock fell more than 49% on May...

A class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging that the company made materially false and misleading statements regarding Fabric Genomics, reimbursement rates durability, and gross margin projections during the period from April 16, 2025 to May 4, 2026. Investors who purchased GeneDx securities during t...

GeneDx Holdings Corp. faces a securities class action lawsuit for failing to disclose material information about its acquisition performance. The company reported a significant drop in adjusted gross margin (74% to 69%), missed revenue estimates, lowered full-year guidance from $540-$550M to $475-$490M, and disclosed a $31.2M impairment loss on i...

GeneDx Holdings Corp. (WGS) faces a securities class action lawsuit over alleged misleading statements regarding its Fabric Genomics acquisition. The company announced a $51 million acquisition in April 2025, but by May 2026 disclosed a $31.2 million impairment charge, a $65 million revenue guidance cut, and a 49.20% single-day stock collapse. Th...